Reneuron Group (RENE)

 

RENE Share PerformanceMore

52 week high3.6750 05/12/16
52 week low1.6000 31/07/17
52 week change -0.9250 (-32.17%)
4 week volume65,186,965 26/07/17

Media for (RENE)

Presenter: Michael Hunt, CEO
04/02/2015

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Neil Woodford 'very confident' he can deliver 10%-plus yearly returns

Woodford Patient Capital's performance has picked up over the last three months and Neil Woodford is optimistic. Marina...

Posting of Annual Report and Notice of AGM

RNS Number: 3171N ReNeuron Group plc 07 August 2017 AIM: RENE 7 August 2017 ReNeuron Group plc ("ReNeuron" or "the Company") Posting of Annual Report and Accounts and Notice of AGM ReNeuron Group plc (AIM: RENE), a leading UK-based stem cell therapy development company, announces that its Annual Report and Accounts for the year ende...

Second Price Monitoring Extn

RNS Number: 2036N ReNeuron Group plc 04 August 2017 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more than a pre-determined p...

Price Monitoring Extension

RNS Number: 2027N ReNeuron Group plc 04 August 2017 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the executio...

Appointment of joint broker

RNS Number: 9482L ReNeuron Group plc 25 July 2017 AIM: RENE 25 July 2017 ReNeuron Group plc Appointment of joint broker ReNeuron Group plc (the "Company") (AIM: RENE), a leading UK-based stem cell therapy development company, is pleased to announce the appointment of Nplus1 Singer Advisory LLP as joint broker to the Company with immedia...

Board change

RNS Number: 4399L ReNeuron Group plc 19 July 2017 AIM: RENE 19 July 2017 ReNeuron Group plc Board change ReNeuron Group plc (the "Company") (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, today announces that Dr Paul Harper , a non-executive director of the business since the Company's flotation on AIM in 200...

ReNeuron widens FY pretax loss

ReNeuron has widened its FY pretax loss to 18.2m, from a loss of 12.8m. This followed its operating loss of 19.9m, from 13.7m...

Preliminary Results

RNS Number: 5135J ReNeuron Group plc 29 June 2017 29 June 2017 AIM: RENE ReNeuron Group plc ("ReNeuron" or "the Company") Preliminary Results for the Year Ended 31 March 2017 ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, is pleased to announce its preliminary results for the year ended 31...

Fundamental DataMore

EPS-0.5
Dividend yield0 %

Equity Research (RENE)

edison investment research
ReNeuron Group plc
06/07/2017
The highlight of FY17 was positive Phase II efficacy data from ReNeuron’s PISCES II clinical trial. As this and its other clinical programmes in ophthalmology and its earlier stage exosome platform...
ReNeuron Group plc
29/06/2017
Westminster Group (WSG.L) 14.91p £15.15m AGM statement from the supplier of managed security services and technology based security solutions to governments and government agencies, non-governmental...
edison investment research
ReNeuron Group plc
02/05/2017
ReNeuron continues to prepare for its Phase III chronic stroke study (due to start in H217) and has indicated that it is making progress with the US/EU regulatory authorities. It intends to submit an...

Latest discussion posts More

  • Re: AGM

    Thanks paul. Incidentally, when do you think we will recover a decent sp, assuming of course, a fair wind.
    21-Aug-2017
    fredd1eboy
  • Re: AGM

    I don't get papers as all my shares are online so to speak but they should be posted on the website when ready. I am 'disproportionately' invested here too Freddie (and ...
    21-Aug-2017
    paulmc1
  • Re: AGM

    Double that and your getting closer grizzly and yes I do feel forgotten along being a lot poorer. All that at a time in my life when I need some financial security. Have a ...
    21-Aug-2017
    fredd1eboy

Users' HoldingsMore

Users who hold Reneuron Group also hold..
LLOYDS GRP.17%
BP12%
BARCLAYS11%
ROCKHOPPER11%
ROYAL BANK SCOT11%

Codes & Symbols

ISINGB00B0DZML60
SymbolsRENE, LSE:RENE, RENE.L, RENE:LN, LON:RENE, XLON:RENE